How Strategic is Ryan Reynolds’ MNTN for New Investors After the IPO?
MNTN, Inc. (NASDAQ: MNTN) is new on the televised advertising space as Mountain.com trying to take ...
Read moreDetails
Tag: IPO
Wall Street Sees Hot IPO Hinging on Significant Strategic upside Ahead
Hinge Health, Inc. (NASDAQ: HNGE) is not your typical health information services company. It has health ...
Read moreDetails
The Newsmax IPO Surge: Strategic to Puzzling
Newsmax debuts on NYSE with a bang! It is not normal for companies to conduct their ...
Read moreDetailsKestra Medical Technologies May Be Overlooked Strategic Homerun
Kestra Medical Technologies, Ltd. (NASDAQ: KMTS) is a recent initial public offering. The wearable medical device ...
Read moreDetailsIs Strategy’s Bitcoin Financing Becoming Too Hot to Handle?
The former MicroStrategy is now just known as Strategy (NASDAQ: MSTR). Despite being the largest corporate ...
Read moreDetails
The Post-IPO Strategic case for Infinity Natural Resources
Infinity Natural Resources, Inc. (NYSE: INR) has seen its post-IPO quiet period come to an end. ...
Read moreDetails
ServiceTitan Strategic investors Case: Huge Opportunities & Some Risks Alike
ServiceTitan, Inc. (NASDAQ: TTAN) came public at a very unusual time when it priced the IPO ...
Read moreDetails
Ingram Micro’s Post-IPO Strategic case Cuts Both Ways
Ingram Micro Holding Corporation (NYSE: INGM) is public once again. After its private equity-backed offering of ...
Read moreDetails
Post-IPO Watch on Camp4: Buy, Sell, Hold or Avoid?
This is the post-IPO drug pipeline image for Camp4 Therapeutics. CAMP4 Therapeutics Corporation (NASDAQ: CAMP) just ...
Read moreDetailsStandardAero’s Post-IPO Strategic case: Buy, Sell, Hold or Avoid?
StandardAero, Inc. (NYSE: SARO) priced its initial public offering of 60 million shares (upsized from 46.5 ...
Read moreDetails
Oggonomics delivers daily stock analysis, Wall Street analyst coverage, and no-nonsense market commentary for investors who think for themselves.
Learn more
